European journal of clinical pharmacy: atención farmacéutica

• 

  Año 2013, Vol. 15, Número 4

  • Editorial

    • "Evergreening" and the life cycle of drugs

      Jaime E. Poquet Jornet

      págs. 227-228

      

  • Originales

    • Erlotinib: Efficacy in non-small cell lung cancer (2nd and subsequent lines of therapy)

      Juan Moll Sendra, Asunción Albert Marí, Enrique Soler Company

      • Resumen

      págs. 230-236

      

    • Improvement strategy on drug interactions in hospital environment

      Lorena Rentero Redondo, Carles Iniesta Navalón, Elena Urbieta Sanz, Celia García-Molina Sáez, Abel Trujillano Ruiz

      • Resumen

      págs. 237-243

      

    • Efficacy and cost effectiveness of anti-TNF drugs for reumatoid arthritis treatment

      Alejandro González Álvarez, Manuel Gómez Barrera, Joaquín Borrás Blasco, Emilio J. Giner Serret

      • Resumen

      págs. 244-254

      

    • The use of bevacizumab profile in the treatment of cancer patients

      Juan Francisco Marín Pozo, Almudena Alcalá Sanz, Isabel Caba Porras, Laura Marín Caba, Ana Acuña Vega

      • Resumen

      págs. 255-260

      

    • Trastuzumab induced cardiotoxicity in patients with HER2+ breast cancer

      Elena Capilla Santamaría, B. Benítez García, José Antonio Romero Garrido, P. Zamora Auñon, Gema Casado Abad

      • Resumen

      págs. 261-267

      

    • Efficacy of meropenem in extended/continuous infusion

      Jesús Cotrina Luque, María Victoria Gil Navarro, Héctor Acosta García, José Miguel Cisneros, José Antonio Lepe

      • Resumen

      págs. 268-272

      

    • Prevalence of antiretroviral interactions with concomitant treatment, medicinal plants, drugs and alcohol

      Beatriz Bonaga Serrano, Eva María García Martínez, María Rosa Ortiz Navarro, N. Cano Cuenca, V. Lerma Gaude

      • Resumen

      págs. 273-278

      

  • Revisión

    • Therapeutic interchange programs in Spain and abroad

      Carmen García Muñoz, Carolina Alarcón Payer, Irene Cañamares Orbis, Mª Jesús Jiménez Cerezo, José Miguel Ferrari Piquero

      • Resumen

      págs. 279-285

      

  • Comunicaciones breves

    • Corticosteroid chronic respiratory diseases with risk of aspergillosis

      Cristina Martínez Roca, Hector José Mozo Peñalver

      • Resumen

      págs. 286-289

      

    • Dental and toungue staining related to imipenem/cilastatin

      Hector José Mozo Peñalver, Cristina Martínez Roca

      • Resumen

      págs. 290-291

      

    • Nitrofurantoin induced adverse effects: COP-BOOP

      José María Merino Muxika, M. Álvares, Pablo Ruiz Sada, Itziar Garmendia Antía, M. López Martínez

      págs. 292-294

      

    • Glucarpidase rescue in patients with high-dose methotrexate toxicity

      J. Ruiz Ramos, J. Reig Aguado, Paloma Escobar Cava, Eduardo López Briz, José Luis Poveda Andrés

      • Resumen

      págs. 295-298

      

    • Phenytoin and acenocoumarol: Drug interactions with clinical impact

      Carmen López Martín, D. Urdiales, Vicente Faus Felipe

      • Resumen

      págs. 299-300

      

    • Case report of an interaction amongst opioids, selective serotonin reuptake inhibitors and COX-2 inhibitor

      María Jesús Rodríguez Arcas, Emilio García Jiménez, Pablo Conesa Zamora

      págs. 301-302